{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:31:17Z","timestamp":1768483877136,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Otsuka Toshimi Scholarship Foundation"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.xphs.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:12:44Z","timestamp":1532477564000},"page":"2946-2956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Various Pharmaceutical Excipients on the Intestinal Transport and Absorption of Sulfasalazine, a Typical Substrate of Breast Cancer Resistance Protein Transporter"],"prefix":"10.1016","volume":"107","author":[{"given":"Kasirawat","family":"Sawangrat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kusamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyasu","family":"Sakane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"ABC transporters: from microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu Rev Cell Biol"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.011_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum Genomics"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.011_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.sbi.2007.07.003","article-title":"Structure and mechanism of ABC transporter proteins","volume":"17","author":"Hollenstein","year":"2007","journal-title":"Curr Opin Struct Biol"},{"issue":"26","key":"10.1016\/j.xphs.2018.07.011_bib4","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A\u00a0multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.011_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bcp.2005.05.031","article-title":"Distribution of breast cancer resistance protein (BCRP\/ABCG2) mRNA expression along the human GI tract","volume":"70","author":"Gutmann","year":"2005","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2018.07.011_bib6","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.011_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","article-title":"The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane","volume":"73","author":"Huls","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.011_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/mol.107.034751","article-title":"Effect of breast cancer resistance protein (Bcrp\/Abcg2) on the disposition of phytoestrogens","volume":"72","author":"Enokizono","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.011_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nm1186","article-title":"The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk","volume":"11","author":"Jonker","year":"2005","journal-title":"Nat Med"},{"issue":"47","key":"10.1016\/j.xphs.2018.07.011_bib10","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","article-title":"Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)","volume":"22","author":"Doyle","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport\u2014an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib12","first-page":"47","article-title":"Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein","volume":"60","author":"Rabindran","year":"2000","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.011_bib13","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in\u00a0vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.011_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/jpet.115.225482","article-title":"The inhibitor Ko143 is not specific for ABCG2","volume":"354","author":"Weidner","year":"2015","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.011_bib15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.65.6.1485","article-title":"High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter","volume":"65","author":"Ozvegy-Laczka","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"22","key":"10.1016\/j.xphs.2018.07.011_bib16","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1158\/0008-5472.CAN-07-2686","article-title":"Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance","volume":"67","author":"Shi","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.011_bib17","first-page":"1195","article-title":"Potentiation of drug effect by tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin","volume":"32","author":"Riehm","year":"1972","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.011_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jps.20017","article-title":"Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in\u00a0vitro diffusion chamber method using the isolated rat intestinal membranes","volume":"93","author":"Shono","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.011_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2006.01.020","article-title":"Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in\u00a0vitro transport and in situ absorption studies","volume":"313","author":"Shen","year":"2006","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(03)00163-9","article-title":"Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines","volume":"90","author":"Lo","year":"2003","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.011_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.dmpk.2015.01.002","article-title":"Effects of cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects","volume":"30","author":"Tomaru","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1016\/j.xphs.2018.07.011_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.30.1301","article-title":"Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats","volume":"30","author":"Lin","year":"2007","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.011_bib23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.xphs.2016.01.020","article-title":"Effects of polyoxyethylene alkyl ethers on the intestinal transport and absorption of rhodamine 123: a P-glycoprotein substrate by in\u00a0vitro and in\u00a0vivo studies","volume":"105","author":"Zhao","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.011_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.08.021","article-title":"Effect of excipients on breast cancer resistance protein substrate uptake activity","volume":"124","author":"Yamagata","year":"2007","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.011_bib25","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.011_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/jpet.102.043307","article-title":"Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells","volume":"304","author":"Batrakova","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.011_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejps.2005.01.001","article-title":"Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells","volume":"24","author":"Sha","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.011_bib28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1211\/jpp.60.12.0009","article-title":"Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies","volume":"60","author":"Shen","year":"2008","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2009.10.005","article-title":"Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics","volume":"142","author":"Buyukozturk","year":"2010","journal-title":"J\u00a0Control Release"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.011_bib30","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1211\/jpp.57.12.0006","article-title":"Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts","volume":"57","author":"Mols","year":"2005","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"4-5","key":"10.1016\/j.xphs.2018.07.011_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.011_bib32","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.xphs.2016.09.004","article-title":"Enhanced oral delivery of bisphosphonate by novel absorption enhancers: improvement of intestinal absorption of alendronate by N-acyl amino acids and N-acyl taurates and their absorption-enhancing mechanisms","volume":"105","author":"Nakaya","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.011_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1073\/pnas.96.2.511","article-title":"Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands","volume":"96","author":"Morita","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.011_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2015.12.043","article-title":"Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats","volume":"499","author":"Alama","year":"2016","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2018.07.011_bib35","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1124\/dmd.112.050286","article-title":"Effect of P-glycoprotein and breast cancer resistance protein inhibition on the pharmacokinetics of sunitinib in rats","volume":"41","author":"Kunimatsu","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"16","key":"10.1016\/j.xphs.2018.07.011_bib36","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1158\/0008-5472.CAN-03-4062","article-title":"Mechanism of the pharmacokinetic interaction between methotrexate and Benzimidazoles","volume":"64","author":"Breedveld","year":"2004","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.xphs.2018.07.011_bib37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/dmd.106.014217","article-title":"Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients","volume":"35","author":"Yamagata","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.011_bib38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.2042-7158.1996.tb03937.x","article-title":"Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane","volume":"48","author":"Yamamoto","year":"1996","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"15","key":"10.1016\/j.xphs.2018.07.011_bib39","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in\u00a0vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.011_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2008.03.016","article-title":"Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats","volume":"359","author":"Gao","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2009.06.018","article-title":"The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats","volume":"379","author":"Hamid","year":"2009","journal-title":"Int J Pharm"},{"issue":"52","key":"10.1016\/j.xphs.2018.07.011_bib42","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1021\/bi801644v","article-title":"Membrane topology of the human breast cancer resistance protein (BCRP\/ABCG2) determined by epitope insertion and immunofluorescence","volume":"47","author":"Wang","year":"2008","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.011_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.str.2010.01.017","article-title":"The human breast cancer resistance protein (BCRP\/ABCG2) shows conformational changes with mitoxantrone","volume":"18","author":"Rosenberg","year":"2010","journal-title":"Structure"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.011_bib44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/dmd.108.022046","article-title":"Substrate-dependent breast cancer resistance protein (Bcrp1\/Abcg2)-mediated interactions: consideration of multiple binding sites in in\u00a0vitro assay design","volume":"37","author":"Giri","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.011_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1021\/bi301532c","article-title":"Lipid bilayer properties control membrane partitioning, binding, and transport of P-glycoprotein substrates","volume":"52","author":"Clay","year":"2013","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/14622416.9.1.105","article-title":"ABC multidrug transporters: structure, function and role in chemoresistance","volume":"9","author":"Sharom","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.011_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nchem.2172","article-title":"A\u00a0subset of annular lipids is linked to the flippase activity of an ABC transporter","volume":"7","author":"Bechara","year":"2015","journal-title":"Nat Chem"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.011_bib48","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1016\/j.xphs.2016.09.002","article-title":"Effects of 2 polyoxyethylene alkyl ethers on the function of intestinal P-glycoprotein and their inhibitory mechanisms","volume":"105","author":"Zhao","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.011_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2009.09.026","article-title":"Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers","volume":"142","author":"Alakhova","year":"2010","journal-title":"J\u00a0Control Release"},{"issue":"49","key":"10.1016\/j.xphs.2018.07.011_bib50","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1021\/jp306565e","article-title":"Understanding the interaction of block copolymers with DMPC lipid bilayer using coarse-grained molecular dynamics simulations","volume":"116","author":"Hezaveh","year":"2012","journal-title":"J\u00a0Phys Chem B"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918304465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918304465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T09:57:09Z","timestamp":1539683829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918304465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0022354918304465"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.07.011","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Various Pharmaceutical Excipients on the Intestinal Transport and Absorption of Sulfasalazine, a Typical Substrate of Breast Cancer Resistance Protein Transporter","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}